Review



inducible nfb ap1 secreted alkaline phosphatase seap reporter  (InvivoGen)


Bioz Verified Symbol InvivoGen is a verified supplier
Bioz Manufacturer Symbol InvivoGen manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    InvivoGen inducible nfb ap1 secreted alkaline phosphatase seap reporter
    Inducible Nfb Ap1 Secreted Alkaline Phosphatase Seap Reporter, supplied by InvivoGen, used in various techniques. Bioz Stars score: 96/100, based on 327 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/hek+blue+htlr2/HEK-Blue+hTLR2+cells/pm42218247-271-8-18
    Average 96 stars, based on 327 article reviews
    inducible nfb ap1 secreted alkaline phosphatase seap reporter - by Bioz Stars, 2026-09
    96/100 stars

    Images

    Related Articles

    Cell Culture:

    Article Title: The monomeric but not homotrimeric spike protein of SARS-CoV-2 activates TLR4 signaling.
    Article Snippet: .. HEK-Blue hTLR2 (hkb-htlr2) and HEK-Blue hTLR4 cells (hkb-htlr4, both from InvivoGen, Toulouse, France) were cultured in growth medium consisting of DMEM (P04-03500, PANBiotech GmbH, Aidenbach, Germany) supplemented with 2 mM L-glutamine (G7513), 100 U/ml penicillin, 100 μg/ml streptomycin (P4333, both from Sigma-Aldrich, Taufkirchen, Germany), and 100 μg/ml normocin (ant-nr-1, InvivoGen). .. Prior to use, HEK-Blue Selection (hb-sel, InvivoGen) was added.

    Article Title: Lipopeptide Hydrogel Possesses Adjuvant-Like Properties for the Delivery of the GPC-3 Peptide-derived Antigen
    Article Snippet: The metabolic activity was measured with PrestoBlue and read by a Varioskan LUX multimode microplate reader (Thermo Scientific) with an excitation wavelength of 560 nm and an emission wavelength of 590 nm. .. HEK-Blue hTLR2 (Cat. hkb-htlr2) derived HEK293 cells were purchased from Invivogen and cultured with Dulbecco’s modified eagle medium (DMEM) with 4.5 g/l-glucose, 2 mm L-glutamine, 10% fetal bovine serum, 1% PenStrep, and Normocin (100μg mL −1 ; Invivogen, Cat. #ant-nr-05). .. Following two passages with Trypsin (GIBCO; Cat. #15050065), the cells were maintained for downstream experiments by adding 1x HEK-Blue Selection to the prepared media following manufacturing protocols.

    Article Title: Lipopeptide Hydrogel Possesses Adjuvant‐Like Properties for the Delivery of the GPC‐3 Peptide‐derived Antigen
    Article Snippet: Peptide-based cancer vaccines are attractive as they can elicit antigen-specific cytotoxic T lymphocytes (CTLs) with minimal side effects.. However, low immunogenic responses have delayed their translation to the clinic.. Adjuvants, which are required in vaccines to boost immunogenicity, currently lack the ability to simultaneously induce specific cell-mediated effects and act as a delivery system.

    Article Title: The monomeric but not homotrimeric spike protein of SARS-CoV-2 activates TLR4 signaling
    Article Snippet: .. HEK-Blue hTLR2 (hkb-htlr2) and HEK-Blue hTLR4 cells (hkb-htlr4, both from InvivoGen, Toulouse, France) were cultured in growth medium consisting of DMEM (P04-03500, PAN-Biotech GmbH, Aidenbach, Germany) supplemented with 2 mM L-glutamine (G7513), 100 U/ml penicillin, 100 μg/ml streptomycin (P4333, both from Sigma-Aldrich, Taufkirchen, Germany), and 100 μg/ml normocin (ant-nr-1, InvivoGen). .. Prior to use, HEK-Blue Selection (hb-sel, InvivoGen) was added.

    Derivative Assay:

    Article Title: Lipopeptide Hydrogel Possesses Adjuvant-Like Properties for the Delivery of the GPC-3 Peptide-derived Antigen
    Article Snippet: The metabolic activity was measured with PrestoBlue and read by a Varioskan LUX multimode microplate reader (Thermo Scientific) with an excitation wavelength of 560 nm and an emission wavelength of 590 nm. .. HEK-Blue hTLR2 (Cat. hkb-htlr2) derived HEK293 cells were purchased from Invivogen and cultured with Dulbecco’s modified eagle medium (DMEM) with 4.5 g/l-glucose, 2 mm L-glutamine, 10% fetal bovine serum, 1% PenStrep, and Normocin (100μg mL −1 ; Invivogen, Cat. #ant-nr-05). .. Following two passages with Trypsin (GIBCO; Cat. #15050065), the cells were maintained for downstream experiments by adding 1x HEK-Blue Selection to the prepared media following manufacturing protocols.

    Article Title: Lipopeptide Hydrogel Possesses Adjuvant‐Like Properties for the Delivery of the GPC‐3 Peptide‐derived Antigen
    Article Snippet: Peptide-based cancer vaccines are attractive as they can elicit antigen-specific cytotoxic T lymphocytes (CTLs) with minimal side effects.. However, low immunogenic responses have delayed their translation to the clinic.. Adjuvants, which are required in vaccines to boost immunogenicity, currently lack the ability to simultaneously induce specific cell-mediated effects and act as a delivery system.

    Modification:

    Article Title: Lipopeptide Hydrogel Possesses Adjuvant-Like Properties for the Delivery of the GPC-3 Peptide-derived Antigen
    Article Snippet: The metabolic activity was measured with PrestoBlue and read by a Varioskan LUX multimode microplate reader (Thermo Scientific) with an excitation wavelength of 560 nm and an emission wavelength of 590 nm. .. HEK-Blue hTLR2 (Cat. hkb-htlr2) derived HEK293 cells were purchased from Invivogen and cultured with Dulbecco’s modified eagle medium (DMEM) with 4.5 g/l-glucose, 2 mm L-glutamine, 10% fetal bovine serum, 1% PenStrep, and Normocin (100μg mL −1 ; Invivogen, Cat. #ant-nr-05). .. Following two passages with Trypsin (GIBCO; Cat. #15050065), the cells were maintained for downstream experiments by adding 1x HEK-Blue Selection to the prepared media following manufacturing protocols.

    Article Title: Lipopeptide Hydrogel Possesses Adjuvant‐Like Properties for the Delivery of the GPC‐3 Peptide‐derived Antigen
    Article Snippet: Peptide-based cancer vaccines are attractive as they can elicit antigen-specific cytotoxic T lymphocytes (CTLs) with minimal side effects.. However, low immunogenic responses have delayed their translation to the clinic.. Adjuvants, which are required in vaccines to boost immunogenicity, currently lack the ability to simultaneously induce specific cell-mediated effects and act as a delivery system.

    Activation Assay:

    Article Title: Lipopeptide Hydrogel Possesses Adjuvant‐Like Properties for the Delivery of the GPC‐3 Peptide‐derived Antigen
    Article Snippet: Peptide-based cancer vaccines are attractive as they can elicit antigen-specific cytotoxic T lymphocytes (CTLs) with minimal side effects.. However, low immunogenic responses have delayed their translation to the clinic.. Adjuvants, which are required in vaccines to boost immunogenicity, currently lack the ability to simultaneously induce specific cell-mediated effects and act as a delivery system.

    Stable Transfection:

    Article Title: Synergistic activation of TLR2 and Dectin-2 by mannose-capped lipoarabinomannan reprograms macrophage lipid metabolism in tuberculosis
    Article Snippet: RAW264.7 cells carrying an EGFP-RelA reporter ( ) were cultured in DMEM containing 10% FBS, 2 mM l-glutamine, 1x penicillin-streptomycin solution (Corning, Manassas, VA), and 10 mM HEPES (Millipore, Billerica, MA) at 37°C and 5% CO 2 . .. The HEK-Blue mDectin-2 and HEK-Blue hTLR2 (InvivoGen, San Diego, CA) are derivatives of HEK293 cells that stably express the murine Dectin-2 and the human TLR2 genes, respectively, along with a NF-κB-inducible reporter system (secreted alkaline phosphatase). .. These cells were maintained in DMEM containing 10% FBS, 4.5Lg/l glucose, 2LmM L-glutamine, 1x penicillin-streptomycin solution, 100Lμg/ml zeocin, 200Lμg/ml hygromycin, 10Lμg/ml blasticidin, 1Lμg/ml puromycin, and 1x TLR and CLR Selection solution (all from InvivoGen, San Diego, CA).



    Similar Products

    96
    InvivoGen inducible nfb ap1 secreted alkaline phosphatase seap reporter
    Inducible Nfb Ap1 Secreted Alkaline Phosphatase Seap Reporter, supplied by InvivoGen, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/hek+blue+htlr2/HEK-Blue+hTLR2+cells/pm42218247-271-8-18
    Average 96 stars, based on 1 article reviews
    inducible nfb ap1 secreted alkaline phosphatase seap reporter - by Bioz Stars, 2026-09
    96/100 stars
      Buy from Supplier

    95
    InvivoGen htlr2
    Htlr2, supplied by InvivoGen, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/hek+blue+htlr2/HEK-Blue+hTLR7+cells/pm42218247-271-1-18
    Average 95 stars, based on 1 article reviews
    htlr2 - by Bioz Stars, 2026-09
    95/100 stars
      Buy from Supplier

    94
    InvivoGen tnfr
    Tnfr, supplied by InvivoGen, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/hek+blue+htlr2/HEK-Blue-Lucia+hTLR2/pm42152018-78-42-49
    Average 94 stars, based on 1 article reviews
    tnfr - by Bioz Stars, 2026-09
    94/100 stars
      Buy from Supplier

    96
    InvivoGen hek dualtm htlr2 cells
    Ef -EVs activate the NF-κB/AP-1 pathways in human reporter macrophages via TLR2 signaling. A dTHP1-XBlue cells were treated with Ef -EVs (100 − 50,000 EVs/cell). LPS (100 ng/mL) was used as a positive control. B dTHP1-XBlue cells were treated with EVs derived from clinical E. faecalis bloodstream isolates (1000-10,000 EVs/cell). LPS (100 ng/mL) and Pam 3 CSK 4 (100 ng/mL) were used as positive controls. C-E) dTHP1-XBlue cells were pretreated with increasing concentrations (from 0.1 to 5 µg/mL) of <t>anti-hTLR2-IgA</t> mAb (dark pink) or human IgA2 control mAb (light pink) for 1 h. Subsequently, cells were treated with either (C) EVs (7000 EVs/cell), (D) Pam 3 CSK 4 (TLR2 ligand, 1 ng/mL), or (E) LPS (TLR4 ligand, 1 ng/mL) in the presence of antibodies for 24 h. Cells treated with cell culture medium supplemented only with Ef -EVs (7000 EVs/cell) in (C, blue), Pam 3 CSK 4 (1 ng/mL) in (D, dark blue), or LPS (1 ng/mL) in (E, red) were used as positive activating controls while cells treated with cell culture medium supplemented alone ( C - E , light green) were used as negative controls. NF-κB/AP-1 activation was measured as the activity of secreted SEAP and expressed as a normalized value relative to the positive controls. Data are shown as means ± SD of three independent experiments ( N = 3, n ≥ 3) and analyzed either by Kruskal-Wallis test followed by Dunn’s multiple comparison post hoc test in (A and B) or by two-way analysis of variance (ANOVA) followed by Šídák multiple comparison post hoc test in ( C - E )
    Hek Dualtm Htlr2 Cells, supplied by InvivoGen, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/hek+blue+htlr2/HEK-Blue+hTLR2+cells/pmc13196059-66-8-30
    Average 96 stars, based on 1 article reviews
    hek dualtm htlr2 cells - by Bioz Stars, 2026-09
    96/100 stars
      Buy from Supplier

    96
    InvivoGen hek bluetm htlr2 cells
    Ef -EVs activate the NF-κB/AP-1 pathways in human reporter macrophages via TLR2 signaling. A dTHP1-XBlue cells were treated with Ef -EVs (100 − 50,000 EVs/cell). LPS (100 ng/mL) was used as a positive control. B dTHP1-XBlue cells were treated with EVs derived from clinical E. faecalis bloodstream isolates (1000-10,000 EVs/cell). LPS (100 ng/mL) and Pam 3 CSK 4 (100 ng/mL) were used as positive controls. C-E) dTHP1-XBlue cells were pretreated with increasing concentrations (from 0.1 to 5 µg/mL) of <t>anti-hTLR2-IgA</t> mAb (dark pink) or human IgA2 control mAb (light pink) for 1 h. Subsequently, cells were treated with either (C) EVs (7000 EVs/cell), (D) Pam 3 CSK 4 (TLR2 ligand, 1 ng/mL), or (E) LPS (TLR4 ligand, 1 ng/mL) in the presence of antibodies for 24 h. Cells treated with cell culture medium supplemented only with Ef -EVs (7000 EVs/cell) in (C, blue), Pam 3 CSK 4 (1 ng/mL) in (D, dark blue), or LPS (1 ng/mL) in (E, red) were used as positive activating controls while cells treated with cell culture medium supplemented alone ( C - E , light green) were used as negative controls. NF-κB/AP-1 activation was measured as the activity of secreted SEAP and expressed as a normalized value relative to the positive controls. Data are shown as means ± SD of three independent experiments ( N = 3, n ≥ 3) and analyzed either by Kruskal-Wallis test followed by Dunn’s multiple comparison post hoc test in (A and B) or by two-way analysis of variance (ANOVA) followed by Šídák multiple comparison post hoc test in ( C - E )
    Hek Bluetm Htlr2 Cells, supplied by InvivoGen, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/hek+blue+htlr2/HEK-Blue+hTLR2+cells/us12622961-363-0-3
    Average 96 stars, based on 1 article reviews
    hek bluetm htlr2 cells - by Bioz Stars, 2026-09
    96/100 stars
      Buy from Supplier

    96
    InvivoGen hek blue nod2
    Receptor-specific activities of individual PRR ligands and conjugated PRR ligands. HEK-Blue <t>NOD2,</t> TLR2, TLR7, TLR4, or HEK-Lucia RIG-I cells were treated with the compounds (1 or 10 μM as indicated) and the corresponding positive controls (1 μM MDP for NOD2, 100 nM Pam3CSK4 for TLR2, 1 μM imiquimod for TLR7, 100 ng/mL LPS for TLR4, and 100 ng/mL Poly­(I/C) for RIG-I) for 18 h. The activities are shown relative to the vehicle-treated control (0.1% DMSO). Data are mean ± SEM of three independent experiments. EC 50 values were determined in HEK-Blue NOD2, TLR2, and TLR7 cells in at least three independent experiments with eight concentrations (1 nM to 10 μM for NOD2 cells, and 0.1 nM to 1 μM for TLR2 and TLR7 cells).
    Hek Blue Nod2, supplied by InvivoGen, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/hek+blue+htlr2/HEK-Blue+hTLR2+cells/pmc13224164-370-0-20
    Average 96 stars, based on 1 article reviews
    hek blue nod2 - by Bioz Stars, 2026-09
    96/100 stars
      Buy from Supplier

    96
    InvivoGen tlr2
    Receptor-specific activities of individual PRR ligands and conjugated PRR ligands. HEK-Blue <t>NOD2,</t> TLR2, TLR7, TLR4, or HEK-Lucia RIG-I cells were treated with the compounds (1 or 10 μM as indicated) and the corresponding positive controls (1 μM MDP for NOD2, 100 nM Pam3CSK4 for TLR2, 1 μM imiquimod for TLR7, 100 ng/mL LPS for TLR4, and 100 ng/mL Poly­(I/C) for RIG-I) for 18 h. The activities are shown relative to the vehicle-treated control (0.1% DMSO). Data are mean ± SEM of three independent experiments. EC 50 values were determined in HEK-Blue NOD2, TLR2, and TLR7 cells in at least three independent experiments with eight concentrations (1 nM to 10 μM for NOD2 cells, and 0.1 nM to 1 μM for TLR2 and TLR7 cells).
    Tlr2, supplied by InvivoGen, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/hek+blue+htlr2/HEK-Blue+hTLR2+cells/pm42087448-425-5-20
    Average 96 stars, based on 1 article reviews
    tlr2 - by Bioz Stars, 2026-09
    96/100 stars
      Buy from Supplier

    94
    InvivoGen hek blue htlr2 tlr1 cells
    Receptor-specific activities of individual PRR ligands and conjugated PRR ligands. HEK-Blue <t>NOD2,</t> TLR2, TLR7, TLR4, or HEK-Lucia RIG-I cells were treated with the compounds (1 or 10 μM as indicated) and the corresponding positive controls (1 μM MDP for NOD2, 100 nM Pam3CSK4 for TLR2, 1 μM imiquimod for TLR7, 100 ng/mL LPS for TLR4, and 100 ng/mL Poly­(I/C) for RIG-I) for 18 h. The activities are shown relative to the vehicle-treated control (0.1% DMSO). Data are mean ± SEM of three independent experiments. EC 50 values were determined in HEK-Blue NOD2, TLR2, and TLR7 cells in at least three independent experiments with eight concentrations (1 nM to 10 μM for NOD2 cells, and 0.1 nM to 1 μM for TLR2 and TLR7 cells).
    Hek Blue Htlr2 Tlr1 Cells, supplied by InvivoGen, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/hek+blue+htlr2/HEK-Blue+hTLR2-TLR1+Cells/pmc13163197-58-0-3
    Average 94 stars, based on 1 article reviews
    hek blue htlr2 tlr1 cells - by Bioz Stars, 2026-09
    94/100 stars
      Buy from Supplier

    94
    InvivoGen hek blue htlr2 tlr6
    Receptor-specific activities of individual PRR ligands and conjugated PRR ligands. HEK-Blue <t>NOD2,</t> TLR2, TLR7, TLR4, or HEK-Lucia RIG-I cells were treated with the compounds (1 or 10 μM as indicated) and the corresponding positive controls (1 μM MDP for NOD2, 100 nM Pam3CSK4 for TLR2, 1 μM imiquimod for TLR7, 100 ng/mL LPS for TLR4, and 100 ng/mL Poly­(I/C) for RIG-I) for 18 h. The activities are shown relative to the vehicle-treated control (0.1% DMSO). Data are mean ± SEM of three independent experiments. EC 50 values were determined in HEK-Blue NOD2, TLR2, and TLR7 cells in at least three independent experiments with eight concentrations (1 nM to 10 μM for NOD2 cells, and 0.1 nM to 1 μM for TLR2 and TLR7 cells).
    Hek Blue Htlr2 Tlr6, supplied by InvivoGen, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/hek+blue+htlr2/HEK-Blue+hTLR2-TLR6+Cells/pm41962328-330-7-21
    Average 94 stars, based on 1 article reviews
    hek blue htlr2 tlr6 - by Bioz Stars, 2026-09
    94/100 stars
      Buy from Supplier

    Image Search Results


    Ef -EVs activate the NF-κB/AP-1 pathways in human reporter macrophages via TLR2 signaling. A dTHP1-XBlue cells were treated with Ef -EVs (100 − 50,000 EVs/cell). LPS (100 ng/mL) was used as a positive control. B dTHP1-XBlue cells were treated with EVs derived from clinical E. faecalis bloodstream isolates (1000-10,000 EVs/cell). LPS (100 ng/mL) and Pam 3 CSK 4 (100 ng/mL) were used as positive controls. C-E) dTHP1-XBlue cells were pretreated with increasing concentrations (from 0.1 to 5 µg/mL) of anti-hTLR2-IgA mAb (dark pink) or human IgA2 control mAb (light pink) for 1 h. Subsequently, cells were treated with either (C) EVs (7000 EVs/cell), (D) Pam 3 CSK 4 (TLR2 ligand, 1 ng/mL), or (E) LPS (TLR4 ligand, 1 ng/mL) in the presence of antibodies for 24 h. Cells treated with cell culture medium supplemented only with Ef -EVs (7000 EVs/cell) in (C, blue), Pam 3 CSK 4 (1 ng/mL) in (D, dark blue), or LPS (1 ng/mL) in (E, red) were used as positive activating controls while cells treated with cell culture medium supplemented alone ( C - E , light green) were used as negative controls. NF-κB/AP-1 activation was measured as the activity of secreted SEAP and expressed as a normalized value relative to the positive controls. Data are shown as means ± SD of three independent experiments ( N = 3, n ≥ 3) and analyzed either by Kruskal-Wallis test followed by Dunn’s multiple comparison post hoc test in (A and B) or by two-way analysis of variance (ANOVA) followed by Šídák multiple comparison post hoc test in ( C - E )

    Journal: Cell Communication and Signaling : CCS

    Article Title: Extracellular vesicles derived from Enterococcus faecalis : inflammatory activation does not require internalization

    doi: 10.1186/s12964-026-02926-9

    Figure Lengend Snippet: Ef -EVs activate the NF-κB/AP-1 pathways in human reporter macrophages via TLR2 signaling. A dTHP1-XBlue cells were treated with Ef -EVs (100 − 50,000 EVs/cell). LPS (100 ng/mL) was used as a positive control. B dTHP1-XBlue cells were treated with EVs derived from clinical E. faecalis bloodstream isolates (1000-10,000 EVs/cell). LPS (100 ng/mL) and Pam 3 CSK 4 (100 ng/mL) were used as positive controls. C-E) dTHP1-XBlue cells were pretreated with increasing concentrations (from 0.1 to 5 µg/mL) of anti-hTLR2-IgA mAb (dark pink) or human IgA2 control mAb (light pink) for 1 h. Subsequently, cells were treated with either (C) EVs (7000 EVs/cell), (D) Pam 3 CSK 4 (TLR2 ligand, 1 ng/mL), or (E) LPS (TLR4 ligand, 1 ng/mL) in the presence of antibodies for 24 h. Cells treated with cell culture medium supplemented only with Ef -EVs (7000 EVs/cell) in (C, blue), Pam 3 CSK 4 (1 ng/mL) in (D, dark blue), or LPS (1 ng/mL) in (E, red) were used as positive activating controls while cells treated with cell culture medium supplemented alone ( C - E , light green) were used as negative controls. NF-κB/AP-1 activation was measured as the activity of secreted SEAP and expressed as a normalized value relative to the positive controls. Data are shown as means ± SD of three independent experiments ( N = 3, n ≥ 3) and analyzed either by Kruskal-Wallis test followed by Dunn’s multiple comparison post hoc test in (A and B) or by two-way analysis of variance (ANOVA) followed by Šídák multiple comparison post hoc test in ( C - E )

    Article Snippet: Upon NF-κB/AP-1 and/or IL-8 activation via TLR2 stimulation, HEK-DualTM hTLR2 cells secrete SEAP and Lucia luciferase, which can be quantified using the QUANTI-BlueTM solution and the QUANTI-LucTM (cat. no. rep-qlc1, Invivogen), respectively.

    Techniques: Positive Control, Derivative Assay, Control, Cell Culture, Activation Assay, Activity Assay, Comparison

    TLR2 controls EV-induced immune activation but does not function as an endocytic receptor for EV uptake. dTHP1-XBlue cells were pretreated with anti-hTLR2-IgA mAb (1 µg/mL) or human IgA2 control mAb (1 µg/mL) for 1 h. Cells were then treated with DiI-labeled Ef -EVs (7000 EVs/cell) in the presence of antibodies for 4 and 24 h. Cells incubated in cell culture medium alone were used as negative controls. Cells treated with cell culture medium supplemented with DiI-labeled Ef -EVs (7000 EVs/cell) were used as positive activating controls. For EV internalization assays, mean fluorescence intensity (B and C, upper panel) and EV-positive cells (B and C, lower panel) were quantified after 4 ( A and B ) and 24 h ( A and C ) of EV treatment by measuring fluorescence intensity associated with DiI-labeled Ef -EVs on the PE channel. NF-κB/AP-1 activation in D was measured after 24 h of EV incubation as the activity of secreted SEAP and expressed normalized to the positive controls. Quantitative results are presented as mean ± SD ( N = 3, n = 3) and were analyzed by Kruskal-Wallis test followed by Dunn’s multiple comparison post hoc test

    Journal: Cell Communication and Signaling : CCS

    Article Title: Extracellular vesicles derived from Enterococcus faecalis : inflammatory activation does not require internalization

    doi: 10.1186/s12964-026-02926-9

    Figure Lengend Snippet: TLR2 controls EV-induced immune activation but does not function as an endocytic receptor for EV uptake. dTHP1-XBlue cells were pretreated with anti-hTLR2-IgA mAb (1 µg/mL) or human IgA2 control mAb (1 µg/mL) for 1 h. Cells were then treated with DiI-labeled Ef -EVs (7000 EVs/cell) in the presence of antibodies for 4 and 24 h. Cells incubated in cell culture medium alone were used as negative controls. Cells treated with cell culture medium supplemented with DiI-labeled Ef -EVs (7000 EVs/cell) were used as positive activating controls. For EV internalization assays, mean fluorescence intensity (B and C, upper panel) and EV-positive cells (B and C, lower panel) were quantified after 4 ( A and B ) and 24 h ( A and C ) of EV treatment by measuring fluorescence intensity associated with DiI-labeled Ef -EVs on the PE channel. NF-κB/AP-1 activation in D was measured after 24 h of EV incubation as the activity of secreted SEAP and expressed normalized to the positive controls. Quantitative results are presented as mean ± SD ( N = 3, n = 3) and were analyzed by Kruskal-Wallis test followed by Dunn’s multiple comparison post hoc test

    Article Snippet: Upon NF-κB/AP-1 and/or IL-8 activation via TLR2 stimulation, HEK-DualTM hTLR2 cells secrete SEAP and Lucia luciferase, which can be quantified using the QUANTI-BlueTM solution and the QUANTI-LucTM (cat. no. rep-qlc1, Invivogen), respectively.

    Techniques: Activation Assay, Control, Labeling, Incubation, Cell Culture, Fluorescence, Activity Assay, Comparison

    TLR2 engagement by Pam 3 CSK 4 -SUVs triggers inflammatory activation but does not enhance SUV internalization. A - C ) dTHP1-XBlue cells were treated with Pam 3 CSK 4 -SUVs (6 µM) containing increasing amounts of Pam 3 CSK 4 (from 0 to 0.4 mol% total SUV lipid composition) for 18 h. Cells incubated in cell culture medium alone were used as negative controls. Cells treated with cell culture medium containing Pam 3 CSK 4 -SUVs (6 µM, Pam 3 CSK 4 composition = 0.4 mol% total SUV lipid composition) were used as positive activating controls. D - F ) dTHP1-XBlue cells were pretreated with anti-hTLR2-IgA mAb (1 µg/mL) or human IgA2 control mAb (1 µg/mL) for 1 h. Cells were then treated with Pam 3 CSK 4 -SUVs (6 µM, Pam 3 CSK 4 composition = 0.04 mol% total SUV lipid composition) in the presence of antibodies for 18 h. Cells treated with cell culture medium containing Pam 3 CSK 4 -SUVs (6 µM, Pam 3 CSK 4 composition = 0.04 mol% total SUV lipid composition) were used as positive activating controls. For both experiments, cells incubated in cell culture medium alone were used as negative controls. Mean fluorescence intensity (B and E, upper panel) and SUV-positive cells (B and E, lower panel) were quantified after 18 h of treatment by measuring fluorescence intensity associated with SUVs on the APC channel. In C and F, NF-κB/AP-1 activation was measured after 18 h of SUV treatment as the activity of secreted SEAP and expressed normalized to the positive controls. Quantitative results are shown as mean ± SD ( N = 3, n = 3) and were analyzed by Kruskal-Wallis test followed by Dunn’s multiple comparison post hoc test

    Journal: Cell Communication and Signaling : CCS

    Article Title: Extracellular vesicles derived from Enterococcus faecalis : inflammatory activation does not require internalization

    doi: 10.1186/s12964-026-02926-9

    Figure Lengend Snippet: TLR2 engagement by Pam 3 CSK 4 -SUVs triggers inflammatory activation but does not enhance SUV internalization. A - C ) dTHP1-XBlue cells were treated with Pam 3 CSK 4 -SUVs (6 µM) containing increasing amounts of Pam 3 CSK 4 (from 0 to 0.4 mol% total SUV lipid composition) for 18 h. Cells incubated in cell culture medium alone were used as negative controls. Cells treated with cell culture medium containing Pam 3 CSK 4 -SUVs (6 µM, Pam 3 CSK 4 composition = 0.4 mol% total SUV lipid composition) were used as positive activating controls. D - F ) dTHP1-XBlue cells were pretreated with anti-hTLR2-IgA mAb (1 µg/mL) or human IgA2 control mAb (1 µg/mL) for 1 h. Cells were then treated with Pam 3 CSK 4 -SUVs (6 µM, Pam 3 CSK 4 composition = 0.04 mol% total SUV lipid composition) in the presence of antibodies for 18 h. Cells treated with cell culture medium containing Pam 3 CSK 4 -SUVs (6 µM, Pam 3 CSK 4 composition = 0.04 mol% total SUV lipid composition) were used as positive activating controls. For both experiments, cells incubated in cell culture medium alone were used as negative controls. Mean fluorescence intensity (B and E, upper panel) and SUV-positive cells (B and E, lower panel) were quantified after 18 h of treatment by measuring fluorescence intensity associated with SUVs on the APC channel. In C and F, NF-κB/AP-1 activation was measured after 18 h of SUV treatment as the activity of secreted SEAP and expressed normalized to the positive controls. Quantitative results are shown as mean ± SD ( N = 3, n = 3) and were analyzed by Kruskal-Wallis test followed by Dunn’s multiple comparison post hoc test

    Article Snippet: Upon NF-κB/AP-1 and/or IL-8 activation via TLR2 stimulation, HEK-DualTM hTLR2 cells secrete SEAP and Lucia luciferase, which can be quantified using the QUANTI-BlueTM solution and the QUANTI-LucTM (cat. no. rep-qlc1, Invivogen), respectively.

    Techniques: Activation Assay, Incubation, Cell Culture, Control, Fluorescence, Activity Assay, Comparison

    Receptor-specific activities of individual PRR ligands and conjugated PRR ligands. HEK-Blue NOD2, TLR2, TLR7, TLR4, or HEK-Lucia RIG-I cells were treated with the compounds (1 or 10 μM as indicated) and the corresponding positive controls (1 μM MDP for NOD2, 100 nM Pam3CSK4 for TLR2, 1 μM imiquimod for TLR7, 100 ng/mL LPS for TLR4, and 100 ng/mL Poly­(I/C) for RIG-I) for 18 h. The activities are shown relative to the vehicle-treated control (0.1% DMSO). Data are mean ± SEM of three independent experiments. EC 50 values were determined in HEK-Blue NOD2, TLR2, and TLR7 cells in at least three independent experiments with eight concentrations (1 nM to 10 μM for NOD2 cells, and 0.1 nM to 1 μM for TLR2 and TLR7 cells).

    Journal: Journal of Medicinal Chemistry

    Article Title: Probing Immune Signatures of Conjugated Pattern Recognition Receptor Ligands Identifies Chimeras with Potent Adjuvant and Antitumor Activities

    doi: 10.1021/acs.jmedchem.6c00372

    Figure Lengend Snippet: Receptor-specific activities of individual PRR ligands and conjugated PRR ligands. HEK-Blue NOD2, TLR2, TLR7, TLR4, or HEK-Lucia RIG-I cells were treated with the compounds (1 or 10 μM as indicated) and the corresponding positive controls (1 μM MDP for NOD2, 100 nM Pam3CSK4 for TLR2, 1 μM imiquimod for TLR7, 100 ng/mL LPS for TLR4, and 100 ng/mL Poly­(I/C) for RIG-I) for 18 h. The activities are shown relative to the vehicle-treated control (0.1% DMSO). Data are mean ± SEM of three independent experiments. EC 50 values were determined in HEK-Blue NOD2, TLR2, and TLR7 cells in at least three independent experiments with eight concentrations (1 nM to 10 μM for NOD2 cells, and 0.1 nM to 1 μM for TLR2 and TLR7 cells).

    Article Snippet: HEK-Blue NOD2 (Cat. code: hkb-hnod2), TLR2 (Cat. code: hkb-htlr2), TLR4 (Cat. code: hkb-htlr4), and TLR7 (Cat. code: hkb-htlr7) cell lines (Invivogen, San Diego, CA) are derived from HEK293 cells by cotransfection of hNOD2, hTLR2, hTLR4, or hTLR7 genes, respectively, and a nuclear factor-κB (NF-κB)-inducible secreted embryonic alkaline phosphatase (SEAP) reporter gene.

    Techniques: Control